Latigo Bio IPO

Develops innovative non-opioid pain medicines for rapid, effective relief without addiction risk.

NASDAQ: LTGO

Buy

Buy Private Stock

Sign up to invest in private companies like Latigo Bio before their IPO.

Sell

Sell Private Stock

Sign up to sell private companies like Latigo Bio before their IPO.

Overview

Latigo Bio completed their IPO on August 7, 2026. Now that Latigo Bio is a public company, Nasdaq Private Market does not actively track its performance. The data below is for reference before the company’s IPO.

Latigo Bio is focused on developing innovative non-opioid pain medicines with best-in-class profiles. Their goal is to provide effective, rapid-acting pain relief by targeting pain at its source, without the risk of addiction.

Sector

Healthcare & Life Sciences

Founded

2018

Headquarters

Thousand Oaks, CA

Latigo Bio Funding

Latigo Bio Funding History Pre-IPO

Gain insights into Latigo Bio funding history prior to their IPO, including the funding round, time period, and amount raised.

Financing Round Date Amount Price per share Valuation
Round Date Amount PPS Valuation
Series B Jan 28, 2025 50M
XXXXX
XXXXX
Series A Oct 04, 2023 65M
XXXXX
XXXXX
Series A Sep 30, 2022 35M
XXXXX
XXXXX
Series A Aug 25, 2020 33M
XXXXX
XXXXX
Seed Dec 23, 2019 2M
XXXXX
XXXXX

Access the PPS, Valuation details, and a wealth of other data by signing up. Source: Nasdaq Private Market

Buy

Buy Private Stock

Sign up to invest in private companies like Latigo Bio before their IPO.

Sell

Sell Private Stock

Sign up to sell private companies like Latigo Bio before their IPO.

Latigo Bio Management Team

Latigo Bio people and management – Prior to IPO

  • Board Member
    Kevin Raidy
  • Board Member
    Jim Tananbaum
  • Board Member
    Beth Seidenberg
  • Board Member
    Deborah Palestrant
  • Board Member
    Tim Walbert
  • Board Member
    Nancy Stagliano
  • CEO, Board Member
    Nima Farzan
  • CFO
    Tim Lugo
  • Chief Medical Officer
    Neil Singla

Investors

Major Latigo Bio investors

  • 5AM Ventures

  • Access Biotechnology

  • Qatar Investment Authority (QIA)

  • Cormorant Asset Management

  • Blue Owl Capital

  • Foresite Capital

  • Rock Springs Capital

  • Corner Ventures

  • Deep Track Capital

  • Kern Capital

  • Westlake Village BioPartners

  • Sanofi Ventures

  • UPMC Enterprises

  • Alexandria Venture Investments

Latigo Bio Valuations & Financials

Looking for private company valuations and share price data?

Nasdaq Private Market Data & Intelligence is the private company valuation database covering 4,000+ venture-backed companies with daily pricing, financing history, and secondary market activity. View real-time NPM data on pre-IPO companies including valuations, private company comparable transactions, and historical share price information — the private company due diligence data sources institutional investors rely on.

Similar Companies

Explore companies

like Latigo Bio

  • Insitro-Logo

    insitro

    Healthcare & Life Sciences

    Drug discovery and development company.

  • Lyra Healthcare-Logo

    Lyra

    Healthcare & Life Sciences

    Digital health startup using technology to connect companies and employees to mental health providers.

  • Eikon Therapeutics Inc-Logo

    Eikon Therapeutics

    Healthcare & Life Sciences

    Uses revolutionary technology to discover novel treatments for life-threatening diseases.

  • Curology-Logo

    Curology

    Healthcare & Life Sciences

    Offers personalized prescription skin care medications delivered directly to you.

  • Cedar Inc-Logo

    Cedar

    Healthcare & Life Sciences

    The tech platform uses modern intelligence to improve healthcare financial experiences for everyone.

  • Weareresilience-Logo

    Resilience

    Healthcare & Life Sciences

    Operates as technology-focused biomanufacturing company dedicated to broadening access to complex medicines.

  • Devoted Health

    Healthcare & Life Sciences

    Provides Medicare Advantage plans to improve older Americans' well-being with comprehensive and family-oriented care.

  • Hinge Health-Logo

    Hinge Health

    Healthcare & Life Sciences

    Digital clinic for back, joint, and muscle pain.

  • Cerebral

    Healthcare & Life Sciences

    Telemedicine mental health startup, providing evidence-based therapeutic techniques and medication management.

FAQ

Questions?

We have answers

Buy Latigo Bio Stock

Latigo Bio became publicly traded following its IPO on August 7, 2026, its shares now trade on public stock exchanges under the ticker symbol NASDAQ: LTGO. Before the IPO, Latigo Bio stock was privately held and available only through private market transactions.

If you’re an accredited investor looking to purchase pre-IPO shares in a private company, Nasdaq Private Market can help you get started. Learn more about investing in the private market or sign up for free to explore available opportunities. Learn more about how private company shares trade prior to an IPO on our investors page.

Sell Latigo Bio Stock

Following its IPO on August 7, 2026, Latigo Bio shares trade on public stock exchanges, allowing shareholders to sell stock through a traditional brokerage.

If you currently hold shares in a private company, Nasdaq Private Market may be able to help you explore your sell private company stock. Our platform provides a secure and compliant way to sell your shares on terms that work for both you and the company. To understand how employees sell shares before a company goes public, visit the Employee Shareholders page.

 

Latigo Bio Stock Price

Following the IPO, Latigo Bio stock prices can now be viewed publicly on major exchanges. Investors and interested parties can find the current stock price by searching Latigo Bio’s ticker symbol on financial platforms such as Nasdaq.com or through their preferred brokerage platform.

Latigo Bio Stock Ticker Symbol

Following its IPO on August 7, 2026, Latigo Bio stock now trades on public markets under the ticker symbol NASDAQ: LTGO. You can view real-time stock information through widely used financial data platforms.

Criteria to Sell Latigo Bio Stock

Following the Latigo Bio IPO, public shares can be sold through any brokerage.

Nasdaq Private Market works with employees, ex-employees, and other private company shareholders of pre-IPO companies to sell their shares. The Nasdaq Private Market platform provides a secure and compliant way to sell your shares on terms that work for both you and the company. To learn more about how to sell private company stock, visit the Employee Shareholders page.

Read more about how to sell shares of a private company and eligibility for selling privately held stock:

 

Criteria to Buy or Invest in Latigo Bio Stock

Following Latigo Bio’s initial public offering on August 7, 2026, its shares are now listed on a public exchange and available for purchase through a brokerage account. Investors interested in buying Latigo Bio stock can do so through their preferred broker, just as they would with any other publicly traded security.

Nasdaq Private Market continues to work with investors seeking exposure to private company opportunities prior to IPO. Through structured transactions and curated offerings, investors can participate in private market activity before companies enter the public markets.

Learn more about the Nasdaq Private Market tool kit for investors on the Investor Trading page.

Latigo Bio Stock Settlement

Since Latigo Bio is now publicly traded, public-market share transfers and settlement occur automatically through a brokerage or exchange.

Nasdaq Private Market supports transfer and settlement for privately held company equity. In order to buy or sell private company stock, share ownership must transfer before funds are wired. With Nasdaq Private Market, clients leverage our patented Transfer and Settlement technology which streamlines and manages transfer activity from match to settlement.

To learn more about private company stock Transfer and Settlement, check out the Transfer and Settlement page.

Latigo Bio IPO

Latigo Bio completed its IPO on August 7, 2026, and is now publicly available through major financial sources.